Utilizing Mesenchymal Stem Cells as an Innovative Therapeutic Strategy for Diabetes and Pancreatic Disorders
According to the World Health Organization, an estimated 422 million people worldwide have diabetes. Numerous studies have demonstrated that people with diabetes are at an increased risk of developing both acute and chronic pancreatitis, which increases the risk of developing pancreatic cancer. Considering the lack of effective therapeutic options for pancreatitis and the limited treatment…
